AxReg
By Anestech
AxReg is a digital perioperative documentation platform for anesthesiologists, available on iOS.
The App DNA
What makes this app unique?
It replaces paper-based anesthesia records with a cloud-integrated workflow to provide real-time productivity metrics for surgical centers.
For Professional anesthesiologists seeking to digitize perioperative documentation and track surgical productivity metrics.
Key features
Digital replacement for paper-based anesthesia records, supporting pre-anesthetic, trans-operative, and post-anesthetic phases.
Cloud-based portal providing real-time productivity metrics, hours worked, and procedure history for the anesthesiologist.
Input system using tap, hold, and swipe gestures to record drug usage and monitoring data in real-time.
How much does it cost?
AxReg operates as a free tool, serving as a lead-generation entry point for the broader Anestech B2B clinical ecosystem.
Velocity
Active developmentperformanceUX improvementsShow more...
AxReg maintains an active development pace, with two releases shipped in the last three days. The latest version focuses on technical refinements, specifically improving signature rendering and resolving logic conflicts in PDF allergy reporting. Development is currently centered on performance and UX improvements rather than new feature expansion. The team remains consistent in addressing functional stability through frequent, minor updates.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads upset.
How are ratings & reviews evolving?
What users say, by theme
- Frequent performance degradation following the latest update makes professional tasks difficult to complete
1 of 1 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for AxReg
How's the Medical market?
AxReg maintains a 2-star rating across 5 total ratings on the App Store. The low rating relative to its specialized clinical function signals high friction in the core documentation workflow.
The rivals identified
The Analyst's Read
Key takeaways for AxReg
Where is it heading?
The digital perioperative market is consolidating around tools that guarantee zero-downtime documentation. AxReg remains exposed due to performance instability, and unless stability is restored, the current 2-star rating will continue to block new professional adoption.
- Performance degradation in the latest release prevents clinical task completion, which compounds the rating drag already visible on the App Store.
The SWOT
- Gesture-based input system enables real-time recording of drug usage and monitoring data.
- Offline-first capabilities could mitigate performance-related churn during surgical procedures.
Next best moves
Audit stability in the latest release because performance degradation is the top complaint → restore professional trust.
The counter-intuitive read
The free-to-use model is a liability rather than a growth lever…
Read the full takeSince the last report: AxReg has pivoted its development roadmap to prioritize core stability over feature expansion, explicitly acknowledging that current performance regressions block professional adoption.
Bottom line
AxReg must prioritize stability over feature expansion to recover its professional user base, as the current performance regressions render the tool unreliable for clinical documentation.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated